MILLS KENNETH T. (President and CEO) sold 4.2% of their position (20.60K shares) of REGENXBIO INC. on the open market
Open‑market sale worth $163.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/14/2025ACC: 0001562180-25-003822
DirectorOfficer· President and CEO
Since Aug 2018
-20.60K
Net shares
Net seller
$163.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20.60K acquired · 41.20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.60K
Price / share
$3.76
Trade value
$77.46K
% of position
4.3%
5/12/2025
475.10K→495.70K
Common Stock
Direct
Shares
−20.60K
Price / share
$7.91
Trade value
$163.05K
% of position
4.2%
5/12/2025
495.70K→475.10K
Total
Net shares
+0.00
Net value
-$85.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/12/2025 | M · Option Exercise | +20.60K | $3.76 | $77.46K | 4.3% | 475.10K | 495.70K |
| Common Stock Direct | 5/12/2025 | S · Sale | −20.60K | $7.91 | $163.05K | 4.2% | 495.70K | 475.10K |
| Total | +0.00 | -$85.58K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
20.60K shares
Shares
−20.60K
Strike price
3.76
Held after
0.00
Exercisable
—
5/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock20.60K shares | 5/12/2025 | M · Option Exercise | −20.60K | 3.76 | — | 0.00 |